STAT’s Washington correspondents Lev Facher and Nick Florko and Washington editor Erin Mershon unpacked the results of the 2018 midterms in this live chat, looking at how health care issues like drug pricing played in key races, filling in the blanks on state-level politics and ballot initiatives, and explaining what the new, incoming Congress will mean for policymaking around health, science, and medicine.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!


What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy